A Multi-centre, Multi-country Retrospective Cohort Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir
Latest Information Update: 07 Apr 2023
At a glance
- Drugs Remdesivir (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms 909REM
- 30 Oct 2021 Results presented at the 18th European AIDS Conference
- 30 Oct 2021 Results (n=448) presented at the 18th European AIDS Conference
- 21 Oct 2021 According to a Gilead Sciences media release, data from this study will be presented at the 18th European AIDS Conference (EACS 2021).